Voyager Therapeutics Inc (VYGR) Live Share Price, Invest From India

Voyager Therapeutics Inc Stock Performance

as on May 5, 2026 at 6:59 am IST

Day's Low
Day's High
$3.75
Day's Price Range
$3.88
$3.87
3.10%
Downside
0.26%
Upside
52 Week's Low
52 Week's High
$2.65
52-Week Price Range
$5.55
$3.87
31.65%
Downside
43.41%
Upside

Voyager Therapeutics Inc share price movements today

Previous Close: $3.76
Open: $3.75
Volume: 476.2K
Day's Low - High: $3.75 - $3.88
52 Week Low - High: $2.65 - $5.55

Voyager Therapeutics Inc Historical Returns

1 Month Return: -5.05 %
3 Month Return: + 6.21 %
1 Year Return: + 7.74 %
3 Year Return: -53.35 %
5 Year Return: -12.15 %

Voyager Therapeutics Inc Stock Fundamentals & Key Indicators

Check Voyager Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$227.2M

EPS (TTM)

-1.7741

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-124.3M

Revenue (TTM)

40.4M

Profit Margin

-296.53%

Return On Equity TTM

-48.29%

Voyager Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Voyager Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Voyager Therapeutics Inc	BUY	$227.2M	-12.15%	NA	-296.53%
Alnylam Pharmaceuticals Inc	BUY	$39.5B	123.19%	74.59	12.55%
Vertex Pharmaceuticals Inc	BUY	$107.8B	98.21%	27.71	32.94%
BeiGene, Ltd.	NA	$32.7B	NA	118.97	5.37%
Regeneron Pharmaceuticals Inc	BUY	$73.5B	45.4%	17.12	29.65%

Stock Returns calculator for Voyager Therapeutics Inc Stock including INR - Dollar returns

The Voyager Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Voyager Therapeutics Inc investment value today

Current value as on today

₹1,25,059

Returns

₹25,059

(+25.06%)

Returns from Voyager Therapeutics Inc Stock

₹10,888 (+10.89%)

Dollar Impact

₹14,171 (+14.17%)

Analyst Recommendation on Voyager Therapeutics Inc Stock

Based on 16 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Voyager Therapeutics Inc. Average target price of $14.89

Voyager Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Voyager Therapeutics Inc.

What analysts predicted

74.01%UPSIDE

Target Price

$14.89

Current Price

$3.87

Analyzed by

16 Analysts

Target

$14.89

Voyager Therapeutics Inc target price $14.89, a slight upside of 74.01% compared to current price of $3.87. According to 16 analysts rating.

Voyager Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Voyager Therapeutics Inc Stock has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 5, 2026 to May 5, 2026

Change:-48% versus previous 30 day period

Voyager Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	4	90	19	29	24	6	6	5	13	15
Gross Profit	-21	88	18	-2	24	6	6	5	13	15
Operating Income	-29	54	-16	-15	-13	-38	-34	-36	-30	-29
EBITDA	-28	58	-14	-11	-12	-37	-33	-35	-26	-28
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	1	1	1	1	1	1	1	0	1
Income Before Tax	-25	57	-11	-10	-9	-33	-30	-33	-27	-27
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-25	56	-11	-10	-9	-34	-31	-33	-27	-27
Net Profit Margin	-561.36%	62.62%	-58.05%	-34.29%	-36.72%	-549.33%	-479.24%	-641.96%	-208.69%	-178.83%

Voyager Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	14	10	7	104	171	37	40	250	80	40
Gross Profit	14	10	7	104	62	37	40	157	80	40
Operating Income	-41	-71	-91	-51	27	-73	-50	122	-83	-131
EBITDA	-40	-70	-88	-48	31	-68	-44	126	-78	-127
Interest Expense	0	-	-	-	-	0	1	-	-	-
Depreciation	-	1	2	2	3	5	6	4	4	4
Income Before Tax	-40	-70	-88	-43	36	-71	-46	133	-64	-119
Income Tax Expense	0	-1	0	-2	-1	-5	0	1	0	0
Net Income	-40	-70	-88	-40	36	-66	-46	132	-65	-119
Net Profit Margin	-282.65%	-697.56%	-1158.79%	-39.11%	21.47%	-176.49%	-113.45%	52.93%	-81.25%	-296.53%

Voyager Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	56	-11	-10	-9	-34	-31	-33	-27	-27
Operating Cash Flow	-23	58	-31	-27	-14	-37	-33	-31	-30
Investing Cash Flow	26	-96	-35	64	-27	41	1	34	47
Financing Cash Flow	0	112	0	0	0	0	0	0	0
Change in Cash	3	75	-66	36	-41	3	-30	1	17

Voyager Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-70	-88	-43	36	-71	-46	132	-65	-119
Operating Cash Flow	-61	-15	48	-96	-53	-12	77	-15	-132
Investing Cash Flow	-3	26	-90	112	65	-7	-141	-94	125
Financing Cash Flow	59	4	80	3	0	1	33	114	0
Change in Cash	-5	15	39	18	12	-18	-30	3	-6

Global Institutional Holdings in Voyager Therapeutics Inc

Funds	Holdings
Millennium Management LLC	4.12%
UBS Group AG	0.79%
Fiduciary Trust Co	0.56%
Royal Bank of Canada	0.52%
JPMorgan Chase & Co	0.73%

See all

Insights on Voyager Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 5.2M → 15.33M (in $), with an average increase of 37.0% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -33.38M → -27.42M (in $), with an average increase of 10.7% per quarter
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 16.2% return, outperforming this stock by 8.5%
NO EFFECT
Against Peers
In the last 3 years, Voyager Therapeutics, Inc. has experienced a drawdown of -53.3%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 45.3%
NEGATIVE IMPACT
Price Dip
In the last 1 month, VYGR stock has moved down by -5.1%

About Voyager Therapeutics Inc

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease. The company also provides research program for the treatment of Huntington's disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Transition Bio, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.

Organisation	Voyager Therapeutics Inc
Headquarters	75 Hayden Avenue, Lexington, MA, United States, 02421
Industry	Biotechnology
CEO	Dr. Alfred W. Sandrock Jr., M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Voyager Therapeutics Inc

Name	Title
Dr. Nathan D. Jorgensen M.B.A., Ph.D.	Chief Financial Officer
Mr. Todd Carter Ph.D.	Chief Scientific Officer
Mr. Gregory Shiferman	Senior VP, General Counsel & Secretary
Ms. Trista Morrison	Chief Corporate Affairs Officer & Chief of Staff to the CEO
Dr. Alfred W. Sandrock Jr., M.D., Ph.D.	President, CEO & Director
Ms. Robin Swartz	Chief Business Officer & COO
Dr. Krystof Bankiewicz M.D., Ph.D.	Founder
Dr. Mark A. Kay M.D., Ph.D.	Founder
Dr. Mathieu Nonnenmacher Ph.D.	Vice President of Gene Therapy

FAQs

What is Voyager Therapeutics Inc share price today?

Voyager Therapeutics Inc share price today is $3.87 as on May 5, 2026 at 1:29 am IST at the close of the market. Voyager Therapeutics Inc share today touched a day high of $3.88 and a low of $3.75.

What is the 52 week high and 52 week low for Voyager Therapeutics Inc share?

Voyager Therapeutics Inc share touched a 52 week high of $5.55 on January 1, 1970 and a 52 week low of $2.65 on January 1, 1970. Voyager Therapeutics Inc stock price today i.e. May 5, 2026 at 1:29 am IST is closed at $3.87,which is 30.27% down from its 52 week high and 46.31% up from its 52 week low.

What is Voyager Therapeutics Inc's market capitalisation today?

Voyager Therapeutics Inc market capitalisation is $0.00T as on May 5, 2026 at 1:29 am IST.

How to invest in Voyager Therapeutics Inc Stock (VYGR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Voyager Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Voyager Therapeutics Inc Shares that will get you 0.3876 shares as per Voyager Therapeutics Inc share price of $3.87 per share as on May 5, 2026 at 1:29 am IST.

What is the minimum amount required to buy Voyager Therapeutics Inc Stock (VYGR) from India?

Indian investors can start investing in Voyager Therapeutics Inc (VYGR) shares with as little as ₹95.067 or $1 (as of May 5, 2026 at 2:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹950.67 in Voyager Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on May 5, 2026 at 2:42 pm IST). Based on Voyager Therapeutics Inc share’s latest price of $3.87 as on May 5, 2026 at 1:29 am IST, you will get 2.5840 shares of Voyager Therapeutics Inc. Learn more about fractional shares .

What are the returns that Voyager Therapeutics Inc has given to Indian investors in the last 5 years?

Voyager Therapeutics Inc stock has given -12.15% share price returns and 28.65% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?